Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Revenue - Other

Vistagen Therapeutics (VTGN) R&D In Process (2020 - 2021)

Vistagen Therapeutics (VTGN) has disclosed R&D In Process for 4 consecutive years, with $5.6 million as the latest value for Q2 2021.